About

Richard Motruk, Chief Operating Officer, Kymanox, has extensive experience in medical device and pharmaceutical manufacturing management, including quality assurance, engineering, maintenance and reliability, technology transfer, clinical research and continuous process improvement. Mr Motruk has been at the forefront of new FDA requirements regarding emergency-use, life-saving devices related to modelled and demonstrated device reliability. Prior to joining Kymanox, he held operating and leadership roles at Teva Pharmaceuticals (Petah Tikva, Israel), OraSure Technologies (PA, US) and bioMérieux (Marcy-l’Étoile, France).

Mr Motruk holds a BSc degree in Biochemistry and Molecular Biology from Pennsylvania State University (US).

Contributions

INJECTION

UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS

Richard Motruk and Nathan Blazei discuss the issues to be considered in light of the US FDA’s tightened reliability standards for emergency-use autoinjectors.